Sedivention
Munich
About Sedivention
Sedivention is a medical technology startup that enables a one-time, interventional, and minimally invasive therapy for obesity. The company is developing a cryo-catheter that ablates the gastric branches of the vagus nerve within minutes. As a one-time, minimally invasive procedure, the procedure can be performed in an outpatient setting, similar to a gastroscopy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $847.6K
- Funding stage: Seed
- Last round: Pre-Seed (Nov 2024)
- Website: sedivention.com
Industries & Categories
Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sedivention-72405 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.